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Introduction
Toxoplasma encephalitis is very common in patients
with AIDS. The diagnosis is based mainly on the
response to medical treatment.
Objectives
To evaluate clinical diagnosis, CT-scan findings, therapy
and evolution of AIDS patients with toxoplasmic
encephalitis.
Material and methods
It was a descriptive cohort study with a prospective and a
retrospective phase. Neurologic deficit was scored by
using the NIHSS (National Institute of Health Stroke
Scale).
Results
Sixty consenting patients were recruited, the mean age
was 38.7 ± 9.7 years. The F/M sex ratio was 1.6. The
mean CD4 cell was 53.5 ± 42.6 /µl. The main presenting
complaints were motor deficits (65 %), seizures (40 %),
headaches (31.7 %), language and the speech disturbances
(35 %). Signs of meningeal irritation and raised intracra-
nial pressure were found in 21 % and 10 % of the cases
respectively.
The brain lesions were all heterogeneous with contrast
enhancement in 80.8 % of cases. Most lesions were supra-
tentorial in 92.3 % of cases, and multilobar in 69.2 %of
cases. Abscesses were multiple in 51.7 % of cases, and
associated with brain herniation in 61.5 % and hydroce-
phalus in 30.8 %.
With adequate treatment, 61.7% had complete resolu-
tion and 13.3 % of the patients, had persistence of neurolo-
gic signs at the end of the intensive treatment period. The
neurologic deficits improved by 50 % by the 7th day of
treatment and even more by the 14th day. The most
encountered treatment options with comparable outcomes
were sulfadiazine-pyrimethamine in 61.7 % of the cases,
followed by Trimethoprime-sulfamethoxazole in 31.1 %.
Conclusion
Focal neurologic deficits of progressive onset, with or
without headache and seizures, are the signs and symp-
toms that alert the suspicion of toxoplasma encephalitis in
HIV-infected patients. Adequate treatment leads to
improvement in neurologic deficits from the first week of
treatment, measured with the NIHSS.
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